Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Stage IB (Resectable)”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Early research (Phase 1)Ended earlyNCT01886573
What this trial is testing

Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing Surgery

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+2 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03433469
What this trial is testing

Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery

Who this might be right for
Stage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung CancerStage IB Non-Small Cell Lung Cancer+4 more
University of California, San Francisco 27
Testing effectiveness (Phase 2)Study completedNCT00963807
What this trial is testing

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Ended earlyNCT03366766
What this trial is testing

Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage IA Non-Small Cell Lung Carcinoma+5 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)Looking for participantsNCT04933903
What this trial is testing

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab

Who this might be right for
Non Small Cell Lung Cancer
Brown University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06682884
What this trial is testing

Lorlatinib as Neoadjuvant Treatment in Stage IB-IIIB ALK-rearranged Non-Small Cell Lung Cancer

Who this might be right for
Neoadjuvant Non-Small Cell Lung Cancer
Peking University People's Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT06532591
What this trial is testing

Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC

Who this might be right for
NSCLC
Sichuan Cancer Hospital and Research Institute 20
Large-scale testing (Phase 3)UnknownNCT06020352
What this trial is testing

The Efficacy and Safety of KN046 Combined With Axitinib

Who this might be right for
NSCLC
Shanghai Pulmonary Hospital, Shanghai, China 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07231575
What this trial is testing

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

Who this might be right for
Neoadjuvant ImmunotherapyNSCLCChemo-free Therapy
Sun Yat-sen University 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06221462
What this trial is testing

Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Ningbo No.2 Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07492342
What this trial is testing

Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSCLC

Who this might be right for
Resectable NSCLCKRAS G12C MutationStage IB-IIIA NSCLC+1 more
Jianxing He 30
Testing effectiveness (Phase 2)Ended earlyNCT04560686
What this trial is testing

Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer

Who this might be right for
Resectable Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+8 more
M.D. Anderson Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT00367679
What this trial is testing

Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLung Cancer, Non-Small Cell
GlaxoSmithKline 35
Large-scale testing (Phase 3)Study completedNCT00321334
What this trial is testing

Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC

Who this might be right for
Non-small Cell Lung Cancer
Chinese Society of Lung Cancer 410
Early research (Phase 1)Ended earlyNCT05088967
What this trial is testing

Efficacy and Safety of IBI110 in Combination With Sintilimab Versus Sintilimab Alone in Neoadjuvant and Adjuvant Therapy of Radically Resectable Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Innovent Biologics (Suzhou) Co. Ltd. 6
Early research (Phase 1)Ended earlyNCT04348292
What this trial is testing

Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8+7 more
Emory University 3
Large-scale testing (Phase 3)Looking for participantsNCT04316364
What this trial is testing

A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 537
Not applicableUnknownNCT06250829
What this trial is testing

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Large-scale testing (Phase 3)Looking for participantsNCT06431633
What this trial is testing

Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.

Who this might be right for
Lung DiseasesCarcinoma, Non-Small-Cell LungResectable Lung Non-Small Cell Carcinoma
Fundación GECP 129
Testing effectiveness (Phase 2)Ended earlyNCT00232206
What this trial is testing

Trial of Neoadjuvant Docetaxel and Cisplatin for Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non-small-Cell Lung Carcinoma
Providence Health & Services 40
Load More Results